Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112574107B reveals a streamlined Pd-catalyzed C-H activation route for high-purity atropisomeric intermediates, offering significant supply chain advantages.
Novel Pd/Cu catalyzed route offers high yields and simplified purification for complex pharmaceutical intermediates, ensuring supply chain stability.
Patent CN115353511A details a safe, multicomponent Pd-catalyzed carbonylation route for indolinone-imidazole hybrids, offering cost reduction in API manufacturing.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering cost-effective and scalable solutions for pharmaceutical manufacturing.
Patent CN116947597B reveals metal-free synthesis for o-iodophenyl acetylene. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable supply and cost-effective API intermediate manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
Patent CN118126005B reveals a metal-free route for fluorinated heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108610278A details Rh(III) catalyzed synthesis offering mild conditions and streamlined operations for cost reduction in fine chemical manufacturing supply chains.
Patent CN111690947B details a metal-free electrochemical method for trifluoromethylation, offering green chemistry solutions and cost reduction in API manufacturing.
Novel iron-catalyzed asymmetric hydrogenation technology using chiral quinoline imidazoline ligands. Reduces noble metal dependency for high-purity pharmaceutical intermediates.
Novel carbonylation cyclization method for N-acyl indoles using solid CO sources. Enhances purity and scalability for pharmaceutical intermediate manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and scalable supply.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering high yields and scalable manufacturing for pharmaceutical applications.
Novel FeCl3-catalyzed route offers high yields and scalability for drug intermediates, reducing costs in API manufacturing.
Patent CN103333144A reveals a high-yield one-pot synthesis for 2-sulfenyl-3-halo benzofurans, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.